The Effects of Chemotherapeutic Agents on Cognitive Function: A Literature Review

Authors

Corinne Menz, University of Arkansas, Fayetteville

Files

Description

Chemotherapy is commonly the first-line treatment for various types of cancers. However, adverse effects resulting from treatment can negatively impact the patient’s quality of life while receiving chemotherapy as well as once the therapy course has been completed. The most commonly experienced effect is chemotherapy related cognitive impairment (CRCI) and is often referred to as “chemobrain”. This review attempts to explore the potential causes of cognitive decline, effects of chemotherapy treatment, and subjective patient reports. Relevant research was compiled in order to understand CRCI and its implications for the care of cancer patients.

Publication Date

2021

Publisher

College of Education and Health Professions Honors Program

City

Fayetteville

Keywords

Expanded Literature Review

Disciplines

Cognitive Science | Medicine and Health Sciences | Nursing

Comments

Advisors:

Kelly Vowell Johnson, Ph.D.
Hope Ballentine, Ph.D.

Citation

Menz, C. (2021). The Effects of Chemotherapeutic Agents on Cognitive Function: A Literature Review. 2021 Honors Symposium. Retrieved from https://scholarworks.uark.edu/coesym21/10